Davis Investment Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,545
| Closed | -$250K | – | 133 |
|
2024
Q3 | $250K | Hold |
2,545
| – | – | 0.1% | 104 |
|
2024
Q2 | $252K | Sell |
2,545
-525
| -17% | -$52K | 0.1% | 101 |
|
2024
Q1 | $276K | Hold |
3,070
| – | – | 0.12% | 94 |
|
2023
Q4 | $275K | Sell |
3,070
-350
| -10% | -$31.3K | 0.13% | 89 |
|
2023
Q3 | $247K | Hold |
3,420
| – | – | 0.13% | 89 |
|
2023
Q2 | $288K | Sell |
3,420
-500
| -13% | -$42.2K | 0.14% | 91 |
|
2023
Q1 | $296K | Hold |
3,920
| – | – | 0.16% | 84 |
|
2022
Q4 | $335K | Buy |
+3,920
| New | +$335K | 0.17% | 86 |
|